Interestingly, ANXA1 has been reported to positively regulate cellular motility in pancreatic cancer [95], which could conceivably link the CEMIP hyaluronidase activity with increased motility, although this remains to be investigated. The gene discussed is CEMIP; the disease is familial pancreatic carcinoma.